Aibotics, Inc. financial data

Symbol
AIBT on OTC
Location
480 22 Nd Street, Heyburn, ID
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 19, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 3.87 % -51.3%
Debt-to-equity -138 % +20%
Return On Equity 54.9 % -16.2%
Return On Assets -146 % -60.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 192M shares +3103%
Common Stock, Shares, Outstanding 51.6M shares +247%
Entity Public Float 1.37M USD -11.5%
Common Stock, Value, Issued 51.6K USD +247%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
General and Administrative Expense 1.77M USD +60.4%
Operating Income (Loss) -1.77M USD -60.2%
Nonoperating Income (Expense) -257K USD +34.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -2.03M USD -35.6%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -2.03M USD -35.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 242K USD -13.6%
Property, Plant and Equipment, Net 0 USD -100%
Intangible Assets, Net (Excluding Goodwill) 943K USD
Assets 1.19M USD -37.2%
Accrued Liabilities, Current 417K USD +11.4%
Liabilities, Current 5.39M USD +12.1%
Liabilities 5.39M USD +12.1%
Retained Earnings (Accumulated Deficit) -11.9M USD -20.6%
Stockholders' Equity Attributable to Parent -4.21M USD -43.9%
Liabilities and Equity 1.19M USD -37.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -28.4K USD +61.5%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 467M shares +367%
Common Stock, Shares, Issued 51.6M shares +247%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 242K USD -13.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 993K USD +79.9%
Deferred Tax Assets, Gross 993K USD +79.9%
Depreciation 0 USD -100%
Deferred Tax Assets, Operating Loss Carryforwards 442K USD +64.7%
Preferred Stock, Shares Authorized 5M shares 0%
Additional Paid in Capital 7.63M USD +10.2%
Interest Expense 201K USD -48.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares